Edward Miller
Conseiller Juridique Général chez ALLOVIR, INC.
Fortune : 407 436 $ au 30/04/2024
Profil
Edward Miller is currently working as the Secretary & General Counsel at AlloVir, Inc. Previously, he worked as the Director-Finance & Accounting at Eloxx Pharmaceuticals, Inc. From 2014 to 2017, he served as the Chief Compliance Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. Prior to that, he held the position of Vice President & Associate General Counsel at Boehringer Ingelheim Corp.
from 2000 to 2014.
Mr. Miller is a graduate of Rutgers Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLOVIR INC
0,44% | 17/05/2024 | 509 295 ( 0,44% ) | 407 436 $ | 30/04/2024 |
Postes actifs de Edward Miller
| Sociétés | Poste | Début |
|---|---|---|
| ALLOVIR, INC. | Conseiller Juridique Général | 01/01/2019 |
Anciens postes connus de Edward Miller
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Compliance Officer | 01/05/2017 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Conseiller Juridique Général | 01/01/2014 |
| ELOXX PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
Formation de Edward Miller
| Princeton University | Undergraduate Degree |
| Rutgers Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |